John F. Milligan
2017
In 2017, John F. Milligan earned a total compensation of $15.4M as President and Chief Executive Officer at Gilead Sciences, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,244,500 |
|---|---|
| Option Awards | $5,749,998 |
| Salary | $1,539,462 |
| Stock Awards | $4,894,499 |
| Other | $10,000 |
| Total | $15,438,459 |
Milligan received $5.7M in option awards, accounting for 37% of the total pay in 2017.
Milligan also received $3.2M in non-equity incentive plan, $1.5M in salary, $4.9M in stock awards and $10K in other compensation.
Rankings
In 2017, John F. Milligan's compensation ranked 271st out of 14,666 executives tracked by ExecPay. In other words, Milligan earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 271 out of 14,666 | 98th |
Division Manufacturing | 81 out of 5,772 | 99th |
Major group Chemicals And Allied Products | 21 out of 2,075 | 99th |
Industry group Drugs | 16 out of 1,731 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 313 | 99th |
Source: SEC filing on March 26, 2018.
Milligan's colleagues
We found five more compensation records of executives who worked with John F. Milligan at Gilead Sciences in 2017.